“You may choose to look the other way, but you can never say again that you did not know.”
— William Wilberforce
In the years just prior to onset of the COVID-19 pandemic in 2019-2020, there was a mysterious polio-like syndrome emerging among some children in the United States, as well as other countries such as India, called acute flaccid myelitis (AFM)—also sometimes referred to as acute flaccid paralysis (AFP). The U.S. Centers for Disease Control and […]
The U.S. Centers for Disease Control and Prevention (CDC) has begun an investigation into reports of myocarditis (heart inflammation) in people between 16 and 45 years of age after receiving either the genetically engineered experimental messenger ribonucleic acid (mRNA) BNT162b2 and mRNA-1273 biologics for COVID-19 developed by Pfizer/BioNTech and Moderna/National Institute of Allergy and Infectious […]
The German biotech firm BioNTech SE issued a joint press release with its American partner Pfizer, Inc. on Nov. 9, 2020 to announce that interim analysis of a global Phase 3 study of their mRNA-based SARS-CoV-2 vaccine appeared to demonstrate an efficacy rate “above 90%”measured seven days after the second dose.1 “This is really a […]
Researchers at the University of Pennsylvania recently reported that they are close to developing a herpes simplex virus 2 (HSV-2) vaccine for humans. HSV-2 primarily causes genital herpes and is contracted through forms of sexual contact with a person who has HSV-2. An estimated 14 percent of Americans between the ages of 15 and 49 […]